Grant Matthew Fischer, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 5 | 2024 | 5824 | 1.060 |
Why?
|
Melanoma | 9 | 2024 | 5690 | 1.030 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2023 | 54 | 0.830 |
Why?
|
Glomus Tumor | 1 | 2023 | 62 | 0.810 |
Why?
|
Herpesvirus 8, Human | 1 | 2023 | 254 | 0.730 |
Why?
|
Sarcoma, Kaposi | 1 | 2023 | 375 | 0.670 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 411 | 0.650 |
Why?
|
Precancerous Conditions | 1 | 2022 | 974 | 0.500 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.410 |
Why?
|
Oxidative Phosphorylation | 3 | 2020 | 502 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4038 | 0.270 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3948 | 0.260 |
Why?
|
Brain Neoplasms | 4 | 2021 | 9071 | 0.260 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 182 | 0.260 |
Why?
|
Oxadiazoles | 2 | 2020 | 94 | 0.210 |
Why?
|
Mutation | 2 | 2024 | 30184 | 0.200 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 523 | 0.180 |
Why?
|
Glutaminase | 1 | 2020 | 32 | 0.180 |
Why?
|
DNA Fingerprinting | 1 | 2021 | 114 | 0.180 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2020 | 38 | 0.170 |
Why?
|
Gene Fusion | 1 | 2023 | 356 | 0.170 |
Why?
|
Scalp | 1 | 2022 | 388 | 0.170 |
Why?
|
Databases, Nucleic Acid | 1 | 2020 | 204 | 0.160 |
Why?
|
Molecular Biology | 1 | 2023 | 574 | 0.160 |
Why?
|
Tissue Array Analysis | 1 | 2020 | 544 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2045 | 0.150 |
Why?
|
Genomics | 2 | 2024 | 5924 | 0.130 |
Why?
|
HIV Infections | 1 | 2023 | 17531 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1048 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1739 | 0.120 |
Why?
|
Piperidines | 2 | 2020 | 1663 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3605 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9522 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1892 | 0.110 |
Why?
|
Mice, Nude | 1 | 2019 | 3614 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1489 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 183 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 1005 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4136 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8603 | 0.090 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6109 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2036 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2454 | 0.090 |
Why?
|
Humans | 16 | 2024 | 765734 | 0.080 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 701 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2024 | 7849 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13448 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11007 | 0.070 |
Why?
|
Mice | 8 | 2021 | 81792 | 0.070 |
Why?
|
Neoplasm Transplantation | 2 | 2021 | 2011 | 0.060 |
Why?
|
Female | 8 | 2024 | 395961 | 0.060 |
Why?
|
Animals | 9 | 2021 | 168731 | 0.060 |
Why?
|
Actins | 1 | 2013 | 2056 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12123 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2011 | 1429 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10262 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 17062 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11865 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5693 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18289 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2941 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5388 | 0.050 |
Why?
|
Aged | 3 | 2024 | 171050 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5336 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59459 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22321 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29899 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2021 | 399 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 593 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 720 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13639 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3969 | 0.030 |
Why?
|
Glycine | 1 | 2020 | 672 | 0.030 |
Why?
|
Proteomics | 2 | 2021 | 3910 | 0.030 |
Why?
|
Serine | 1 | 2020 | 824 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2021 | 2470 | 0.030 |
Why?
|
Male | 3 | 2024 | 363585 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 41631 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1600 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Mass Screening | 1 | 2011 | 5445 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23589 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27178 | 0.030 |
Why?
|
Protein Kinases | 1 | 2019 | 1611 | 0.020 |
Why?
|
Overweight | 1 | 2023 | 2443 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3595 | 0.020 |
Why?
|
Cell Survival | 1 | 2021 | 5747 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1668 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2011 | 315 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2056 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 222903 | 0.020 |
Why?
|
Adult | 1 | 2024 | 222974 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1144 | 0.020 |
Why?
|
Base Sequence | 1 | 2021 | 12402 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2051 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8279 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10069 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1937 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3585 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4642 | 0.020 |
Why?
|
Mitochondria | 1 | 2019 | 3670 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2141 | 0.010 |
Why?
|
Body Mass Index | 1 | 2023 | 13044 | 0.010 |
Why?
|
Immunotherapy | 1 | 2020 | 4752 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2013 | 2862 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6546 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5192 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13079 | 0.010 |
Why?
|
Caregivers | 1 | 2011 | 2307 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14445 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10428 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9441 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 65180 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14637 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 74831 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16706 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7875 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26284 | 0.010 |
Why?
|
Prospective Studies | 1 | 2011 | 54795 | 0.000 |
Why?
|